Southlake has become the world’s first dermatology residency to offer a free melanomas treatment.
It is part of a wider move to provide more free melanin treatments, following the successful trial of a melanoma vaccine.
The trial was carried out in Southlake in collaboration with Southlake General Hospital and the Department of Dermatology. “
This trial has shown the potential of a vaccine to reduce the incidence of melanomas in melanoma patients, but it has been a long road to get to this point.”
The trial was carried out in Southlake in collaboration with Southlake General Hospital and the Department of Dermatology.
A further trial involving over 20,000 patients in the US is planned.
“We are delighted to be partnering with Southgate General Hospital, where the melanomas research is carried out, to introduce free melanoacne therapy in the UK.
The melanoma trial was conducted over 10 years with patients aged from 10 to 70.”
The melanomas vaccine is now on its way to the UK and will be available at Southgate in 2018, and at Southlake at some stage in 2019,” he added.
Dr Clements is currently the chief dermatologist at the Southgate Dermatological Department.
He said he would be keen to see more dermatologists taking up the opportunity to offer melanomas free treatment, and said it was important to treat the disease properly.
For more news on melanoma follow BBC Newsbeat on Twitter and Facebook
